A High-Risk Multiple Myeloma Group Identified By Integrative Multi-Omics Segmentation of Newly Diagnosed Patients

被引：1
|
作者：
Ortiz, Maria [1 ]
Towfic, Fadi [2 ]
Samur, Mehmet Kemal [3 ]
Flynt, Erin [4 ]
Jang, In Sock [5 ]
Wang, Kai [5 ]
Ashby, Cody [6 ]
Walker, Brian A. [6 ]
Trotter, Matthew [7 ]
Morgan, Gareth [8 ]
Munshi, Nikhil [9 ]
Thakurta, Anjan [2 ]
机构：
[1] CITRE, Res Analyt, Seville, Spain
[2] Celgene Corp, Summit, NJ USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA
[4] Celgene Corp, Translat Dev & Diagnost, Summit, NJ USA
[5] Celgene Corp, Res Analyt, San Diego, CA USA
[6] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA
[7] CITRE, Seville, Spain
[8] Myeloma Inst Res & Therapy, Little Rock, AR USA
[9] Harvard Med Sch, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3165
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Roundtable: How I treat a newly diagnosed patient with high-risk myeloma
    Kaufman, Jonathan L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 120 - 124
  • [42] Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics: a retrospective study of the PETHEMA/Spanish Myeloma Group (GEM)
    Villalba, Ana
    Lloret, Pilar
    Rodriguez, Ana Pilar Gonzalez
    Arzuaga-Mendez, Javier
    Puig, Noemi
    Arnao, Mario
    Arguinano, Jose Maria
    Jimenez, Maria
    Canet, Marta
    Teruel, Ana I.
    Sola, Maria
    Diaz, Francisco J.
    Encinas, Cristina
    Garcia, Antonio
    Rosinol, Laura
    Suarez, Alexia
    Gonzalez, Marta Sonia
    Izquierdo, Isabel
    Hernandez, Miguel Teodoro
    Infante, Maria Stefania
    Sanchez, Maria Jose
    Sampol, Antonia
    De la Rubia, Javier
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S158 - S158
  • [43] Integrative Multi-Omics Analysis of Tumor-Immune Microenvironment in Multiple Myeloma: Novel Insights and Therapeutic Implications
    Alaterre, Elina
    Robert, Nicolas
    Requirand, Guilhem
    Machura, Amelie
    De Boussac, Hugues
    Vincent, Laure
    Herbaux, Charles
    Bruyer, Angelique
    Moreaux, Jerome
    BLOOD, 2023, 142
  • [44] Real-World Outcome for Newly Diagnosed Patients with Functional High-Risk Myeloma - a Myeloma and Related Diseases Registry Analysis
    Spencer, Andrew
    Mollee, Peter
    Blacklock, Hilary Anne
    Harrison, Simon
    Quach, Hang
    Ho, P. Joy
    Spearing, Ruth
    Hocking, Jay
    Augustson, Bradley
    Prince, H. Miles
    Moore, Elizabeth M.
    McQuilten, Zoe
    Wood, Erica M.
    Wellard, Cameron
    BLOOD, 2019, 134
  • [45] Early Infection Risk in Newly Diagnosed Multiple Myeloma Patients in the Modern Era
    Stevenson, Ryan
    Carpenter, Diane M.
    Khan, Adnan
    Fatoki, Raleigh
    Rajagopal, Sumanth
    Green, Michael M.
    Nair, Bijay
    Baer, David M.
    BLOOD, 2021, 138 : 3794 - +
  • [46] Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma
    Zhang, Limei
    Chen, Shuzhao
    Huang, Mayan
    Wang, Weida
    Liang, Yang
    Wang, Yun
    ANNALS OF HEMATOLOGY, 2023, 102 (01) : 125 - 132
  • [47] Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study
    Lee, Gin-Yi
    Lee, Yu-Ting
    Yeh, Chiu-Mei
    Hsu, Pei
    Lin, Ting-Wei
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Tzeng, Cheng-Hwai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Liu, Yao-Chung
    Liu, Chia-Jen
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 726 - 733
  • [48] Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma
    Limei Zhang
    Shuzhao Chen
    Mayan Huang
    Weida Wang
    Yang Liang
    Yun Wang
    Annals of Hematology, 2023, 102 : 125 - 132
  • [49] INTEGRATIVE MULTI-OMICS APPROACH FOR STRATIFICATION OF TUMOR RECURRENCE RISK GROUPS OF HEPATOCELLULAR CARCINOMA PATIENTS
    Kaur, Harpreet
    Lathwal, Anjali
    Dhall, Anjali
    Raghava, Gajendra P. S.
    HEPATOLOGY, 2021, 74 : 346A - 347A
  • [50] Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment
    Zheng, Bo
    Yi, Ke
    Zhang, Yajun
    Pang, Tongfang
    Zhou, Jieyi
    He, Jie
    Lan, Hongyan
    Xian, Hongming
    Li, Rong
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3833 - 3846
12345